Exchange Traded Concepts LLC Buys 47,625 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Exchange Traded Concepts LLC boosted its stake in Semler Scientific, Inc. (NASDAQ:SMLR) by 345.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 61,396 shares of the company’s stock after purchasing an additional 47,625 shares during the quarter. Exchange Traded Concepts LLC owned about 0.66% of Semler Scientific worth $3,315,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in SMLR. Cerity Partners LLC lifted its position in shares of Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after buying an additional 642,982 shares in the last quarter. Shariaportfolio Inc. purchased a new stake in shares of Semler Scientific during the 3rd quarter worth approximately $3,618,000. AQR Capital Management LLC boosted its position in shares of Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after acquiring an additional 84,314 shares during the last quarter. Crawford Fund Management LLC bought a new position in shares of Semler Scientific during the 3rd quarter valued at approximately $883,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after purchasing an additional 19,552 shares in the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Price Performance

Shares of NASDAQ SMLR opened at $55.46 on Friday. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56. The business’s 50 day moving average is $60.44 and its two-hundred day moving average is $40.35. The stock has a market capitalization of $513.95 million, a P/E ratio of 27.05 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Wall Street Analyst Weigh In

Separately, Lake Street Capital increased their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.